Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Change in Accured Expenses (2016 - 2025)

Bio Key International's Change in Accured Expenses history spans 16 years, with the latest figure at $43488.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 51.54% year-over-year to $43488.0; the TTM value through Sep 2025 reached -$55038.0, up 46.57%, while the annual FY2024 figure was -$42116.0, 115.28% down from the prior year.
  • Change in Accured Expenses for Q3 2025 was $43488.0 at Bio Key International, down from $128478.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $436339.0 in Q3 2023 and bottomed at -$236321.0 in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $27465.0 (2021), against an average of $34590.2.
  • The largest annual shift saw Change in Accured Expenses surged 54339.3% in 2021 before it plummeted 396.52% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $129575.0 in 2021, then skyrocketed by 34.67% to $174496.0 in 2022, then tumbled by 129.55% to -$51570.0 in 2023, then soared by 118.07% to $9317.0 in 2024, then skyrocketed by 366.76% to $43488.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Change in Accured Expenses are $43488.0 (Q3 2025), $128478.0 (Q2 2025), and -$236321.0 (Q1 2025).